全文获取类型
收费全文 | 21411篇 |
免费 | 1207篇 |
国内免费 | 113篇 |
专业分类
耳鼻咽喉 | 222篇 |
儿科学 | 432篇 |
妇产科学 | 456篇 |
基础医学 | 2755篇 |
口腔科学 | 583篇 |
临床医学 | 1649篇 |
内科学 | 5730篇 |
皮肤病学 | 556篇 |
神经病学 | 1885篇 |
特种医学 | 547篇 |
外科学 | 3323篇 |
综合类 | 106篇 |
现状与发展 | 1篇 |
一般理论 | 4篇 |
预防医学 | 1509篇 |
眼科学 | 390篇 |
药学 | 1066篇 |
中国医学 | 45篇 |
肿瘤学 | 1472篇 |
出版年
2023年 | 159篇 |
2022年 | 298篇 |
2021年 | 823篇 |
2020年 | 361篇 |
2019年 | 709篇 |
2018年 | 843篇 |
2017年 | 481篇 |
2016年 | 496篇 |
2015年 | 568篇 |
2014年 | 791篇 |
2013年 | 1088篇 |
2012年 | 1779篇 |
2011年 | 1681篇 |
2010年 | 965篇 |
2009年 | 894篇 |
2008年 | 1418篇 |
2007年 | 1439篇 |
2006年 | 1346篇 |
2005年 | 1327篇 |
2004年 | 1095篇 |
2003年 | 1032篇 |
2002年 | 976篇 |
2001年 | 155篇 |
2000年 | 105篇 |
1999年 | 166篇 |
1998年 | 159篇 |
1997年 | 145篇 |
1996年 | 126篇 |
1995年 | 127篇 |
1994年 | 103篇 |
1993年 | 91篇 |
1992年 | 87篇 |
1991年 | 75篇 |
1990年 | 54篇 |
1989年 | 52篇 |
1988年 | 50篇 |
1987年 | 43篇 |
1986年 | 49篇 |
1985年 | 43篇 |
1984年 | 42篇 |
1983年 | 28篇 |
1982年 | 29篇 |
1981年 | 42篇 |
1980年 | 28篇 |
1979年 | 34篇 |
1978年 | 33篇 |
1977年 | 22篇 |
1976年 | 28篇 |
1974年 | 21篇 |
1969年 | 23篇 |
排序方式: 共有10000条查询结果,搜索用时 406 毫秒
51.
Felipe A. Calvo David Ortiz de Urbina Luis Sierrasesúmaga Oscar Abuchaibe Ignacio Azinovic Federico Antillon Manuel Santos Jos Canadell 《Pediatric blood & cancer》1991,19(6):478-485
From September 1984 to December 1989, 38 patients of pediatric age with localized bone sarcomas received intraoperative radiotherapy (IORT) as part of a multidisci plinary treatment program. The age ranged from 6 to 21 years. The tumor histologies were 22 osteosarcomas and 16 Ewing's sarcomas. Thirty-four had initial primary disease (90%) and 4 were treated for local recurrence (10%). IORT was used on 32 untreated patients and in 6 previously treated with external beam radiotherapy (EBR). The IORT field included the surgically exposed tumor bed area. Single radiation doses ranging from 10 to 20 Gy were delivered, using 6–20 MeV electron beams. The median follow-up time for the entire group is 25 months (2–65+ months). The projected 5-year disease-free and overall survival rates are 65% and 69%, respectively. One patient developed a local recurrence in each histological group: one chondroblastic osteosarcoma and one cervical Ewing's sarcoma. Six patients died from metastatic progression: 3 initially recurrent tumors and three primary disease cases. Severe neuropathy and soft tissue necrosis were seen in some patients as IORT related complications. IORT is a feasible technique to be integrated in multidisciplinary programs that may promote local control in pediatric and adolescent patients with bone sarcomas. Peripheral nerves are dose-limiting tissue structures for IORT. 相似文献
52.
53.
54.
55.
56.
Manuel Diaz-Llopis Salvador García-Delpech David Salom Patricia Udaondo Francisco Bosch-Morell Arturo Quijada Francisco J Romero Luis Amselem 《Journal of ocular pharmacology and therapeutics》2007,23(4):343-350
PURPOSE: The aim of this study to analyze the preventive effect of high-dose infliximab in endotoxin-induced uveitis (EIU) in rabbits. METHODS: An experimental study was conducted on 64 rabbits. Salmonella typhimurium lipopolysaccharide endotoxin was intravitreally injected. Infliximab was intravenously (i.v.) injected 24 h before the intravitreal injection (20 mg/kg). The animals were randomly assigned to five groups: group A, saline intravitreal injection; group B, Infliximab i.v. group C, infliximab + saline; group D, intravitreal endotoxin and group E, infliximab i.v. + intravitreal endotoxin. With two masked observers, a microscopic examination of aqueous humor (cells, tumor necrosis factor [TNF] alpha) and aqueous protein level were performed 24 h after an endotoxin injection and 48 h after an infliximab infusion. RESULTS: Infliximab treatment, at a dose of 20 mg/kg, significantly improved all the parameters. Inflammatory cell infiltration was significantly reduced in the iris, ciliary body, and anterior chamber (U Mann-Whitney test, P = 0.01). Associated with a lower level of TNF-alpha and protein exudate in aqueous humor (U Mann-Whitney test, P = 0.01). CONCLUSIONS: Infliximab, at a dose of 20 mg/kg, is effective in the prophylaxis of the EIU. 相似文献
57.
Melissa Hurwitz Manuel G Garcia Robert L Poole John A Kerner 《Nutrition in clinical practice》2004,19(3):305-308
The standard of care for patients with cholestasis (direct bilirubin >or=2 mg/dL) while receiving parenteral nutrition (PN) solutions is to reduce or discontinue the copper and manganese. The repercussions of this action have not been studied. Two adult case reports document low serum copper levels associated with clinical symptoms of copper deficiency after the removal of copper from their PN solutions. We now describe the first known series of pediatric patients to develop copper deficiency after copper was removed from their PN solutions. 相似文献
58.
59.